top of page

Téléphone : +918866862020

Heading 4

Heading 4

Heading 4

Heading 4

Heading 4

Heading 4

Heading 4

Heading 4

Heading 4

Heading 4

Heading 4

Heading 4

Aggricease Injection 100ml

Aggricease Injection 100ml

Manufacturer/Marketed By : ARISTO PHARMACEUTICALS PVT LTD

$112.80 $22.57

Aggricease Injection 100ml contains Tirofiban, a glycoprotein IIb/IIIa receptor antagonist used to prevent blood clots in patients with acute coronary syndromes (ACS), including unstable angina and non-ST-elevation myocardial infarction (NSTEMI)....

Collapsible text is perfect for longer content like paragraphs and descriptions. It's a great way to give people more information while keeping your layout clean. Link your text to anything, including an external website or a different page. You can set your text box to expand and collapse when people click, so they can read more or less info.

TIROFIBAN

Active Pharmaceutical Ingredient

Aggricease Injection 100ml

SKU ARISTO PHARMACEUTICALS PVT LTD
Prix d’origine

112,80 $US

Prix promotionnel

22,57 $US

Aggricease Injection 100ml contains Tirofiban, a glycoprotein IIb/IIIa receptor antagonist used to prevent blood clots in patients with acute coronary syndromes (ACS), including unstable angina and non-ST-elevation myocardial infarction (NSTEMI). It works by inhibiting platelet aggregation, which helps maintain smooth blood flow in the arteries and reduces the risk of heart attack or other cardiovascular complications. Aggricease Injection 100ml is usually administered under strict medical supervision in hospitals or specialised care centers. Before using this medicine, inform your doctor if you have a history of bleeding disorders, low platelet count, kidney disease, or recent surgery. Aggricease Injection 100ml price varies by retailer and location.

Active Pharmaceutical Ingredient

TIROFIBAN

Uses

• Preventing blood clots in patients with unstable angina
• Reducing the risk of non-ST-elevation myocardial infarction (NSTEMI)
• Supporting percutaneous coronary intervention (PCI) to prevent platelet aggregation
• Managing acute coronary syndromes in high-risk patients

Benefits

Add paragraph text. Click “Edit Text” to update the font, size and more. To change and reuse text themes, go to Site Styles.Add paragraph text. Click “Edit Text” to update the font, size and more. To change and reuse text themes, go to Site Styles.Add paragraph text. Click “Edit Text” to update the font, size and more. To change and reuse text themes, go to Site Styles.Add paragraph text. Click “Edit Text” to update the font, size and more. To change and reuse text themes, go to Site Styles.Add paragraph text. Click “Edit Text” to update the font, size and more. To change and reuse text themes, go to Site Styles.

Side Effects

Common Aggricease Injection side effects:

Most Common Side Effects

• Severe internal bleeding
• Low platelet count (thrombocytopenia)
• Allergic reactions
• Hypotension

Common Side Effects

• Bleeding at injection site
• Nosebleeds
• Headache
• Dizziness

How To Use

Administered intravenously under strict medical supervision.

Safety Advice

• Pregnancy: Tirofiban should be used during pregnancy only if the benefits outweigh the risks. Inform your doctor if you are pregnant or planning pregnancy.
• Breast Feeding: Consult your doctor before using Tirofiban while breastfeeding, as its safety has not been established.
• Lungs: Caution is advised in patients with respiratory disorders; monitor for bleeding complications.
• Liver: Patients with liver disease should consult their doctor before use, as liver impairment may affect drug metabolism.
• Alcohol: No known interaction with alcohol, but avoid excessive consumption during treatment due to cardiovascular risk.
• Driving: Tirofiban does not usually affect alertness, but avoid driving immediately after hospital discharge if feeling weak or dizzy.

Disclaimer

Sidmex Inovia s'efforce de fournir des informations exactes et fiables. Cependant, l'ensemble du contenu de ce site web, y compris les descriptions et compositions des produits, est fourni à titre informatif uniquement et ne saurait se substituer à un avis, un diagnostic ou un traitement médical professionnel.

Il est conseillé aux utilisateurs de consulter un professionnel de santé qualifié avant toute décision médicale. Les informations fournies ne doivent pas être utilisées pour l'autodiagnostic ou l'automédication.

Tous les produits présentés sont exclusivement destinés aux professionnels (B2B) et aux demandes de renseignements en gros. Sidmex Inovia ne promeut pas la consommation directe par les particuliers et vise à soutenir, et non à remplacer, la relation entre le professionnel de santé et le patient.

Les noms de produits, marques et logos appartiennent à leurs propriétaires respectifs et leur utilisation n'implique aucune affiliation ni aucun parrainage. Sidmex Inovia décline toute responsabilité quant aux conséquences découlant de l'utilisation des informations fournies sur ce site web.

bottom of page